Researchers Overdosing COVID-19 Patients on Hydroxychloroquine, States Association of American Physicians & Surgeons (AAPS)
TUCSON, Ariz., June 17, 2020 /PRNewswire/ -- Until President Trump suggested that hydroxychloroquine (HCQ, Plaqueniltm) might help COVID-19 patients, it was generally considered a very safe drug, observes the Association of American Physicians & Surgeons (AAPS). It was approved by the FDA in 1955 and has been used by hundreds of millions of patients worldwide for malaria, lupus, and rheumatoid arthritis. Physicians do not generally require an electrocardiogram before prescribing it.
Apparently because of alarming media coverage, many patients are now expressing fear that HCQ is dangerous because of cardiac effects, states AAPS. Outgoing AMA president Patrice Harris, M.D., told the media that "you could lose your life."
Widely reported studies have been stopped because of lack of benefit in seriously ill hospitalized COVID-19 patients and the occurrence of cardiac rhythm disturbances. AAPS notes the following:
Late in the disease, antivirals are unlikely to help because patients are dying of organ damage and blood clots, possibly due to immune overreaction.
The SARS-CoV-2 virus may infect the heart, and this may cause arrhythmias.
Doses of HCQ in some trials, such as the UK's "Recovery" trial and the multinational World Health Organization (WHO) Solidarity trial may be toxic or even lethal, and much higher than recommended for any medical condition. The cumulative dose of this long-acting drug in the "Recovery" trial (9.6 grams) is four times as high as used in India.
Americans are being urged to "follow the science." But AAPS asks: "How can we trust the established authorities or prestigious journals when, in this perilous time, trials of an available, inexpensive, long-established drug appear to be designed to fail, while risking the lives of their subjects through deliberate or negligent drug overdoses?"
BioArctic AB (publ) today announced that BioArctic AB and Eisai Co., Ltd., have entered into a research evaluation agreement regarding BAN2802, a potential new treatment combining BioArctic's proprietary BrainTransportertm technology with an...
LifeLabs workers from Orillia, Barrie, Collingwood, and Wasaga Beach will rally with community members and allies ahead of their imminent strike deadline. They stand firm in their demands for a fair contract that puts patients and workers before...
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...